Biktarvy, formally known as bictegravir sulfate, includes a potent single-tablet treatment for managing HIV infection. This medication integrates three key antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by inhibiting the HIV's ability to copy within the body, considerably reducing the viral load. For many in